Improving the experience of obtaining repeat complex paediatric prescriptions in the UK

Yincent Tse1,2, Ashifa Trivedi3, Abigail Mee4

  • 1Department of Paediatric Nephrology, Great North Children's Hospital, Newcastle upon Tyne, UK yincenttse@nhs.net.

Insights

Managing medicines for children with chronic conditions in the UK is complex. This study identifies barriers and solutions for medication supply challenges faced by families navigating primary and specialist care.

Area of Science:

  • Pediatrics
  • Pharmacology
  • Healthcare Management

Background:

  • Children and young people (CYP) with chronic conditions often have medications initiated in secondary or tertiary care.
  • Ongoing medication supply is typically transferred to general practitioners (GPs) and community pharmacists.
  • Ideal care involves regular specialist reviews and seamless communication between primary and secondary/tertiary care.

Purpose of the Study:

  • To identify barriers in the current system for supplying medicines to children and young people with chronic conditions.
  • To propose potential solutions to improve medication access and management for this population.
  • To highlight the complexities families face in navigating fragmented healthcare systems.

Main Methods:

  • The article outlines observed challenges within the UK healthcare system.
  • It discusses the variability in medication prescribing and supply arrangements across different regions.
  • The authors define 'specialist prescribers' broadly to include various medical and non-medical professionals involved in CYP care.

Main Results:

  • The reality of medication supply for CYP is often fragmented, requiring families to source medicines from multiple providers (GPs, hospitals, homecare).
  • Arrangements are non-uniform across the UK and depend on prescriber acceptance.
  • Families frequently feel unsupported in navigating this complex and variable system.

Conclusions:

  • Significant barriers exist in the UK's system for supplying chronic condition medicines to children and young people.
  • Improved communication and standardized processes are needed between primary, secondary, and tertiary care.
  • Addressing these systemic issues is crucial for ensuring consistent and accessible medication for CYP.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
11
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
12
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
10
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
17
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
21
Prescription, Nonprescription and Orphan Drugs01:02

Prescription, Nonprescription and Orphan Drugs

Prescription drugs require a prescription from a medical practitioner and can only be obtained from a pharmacy. They have many applications, including treating pain, anxiety, and hypertension.
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
885